Provided by Tiger Fintech (Singapore) Pte. Ltd.

LIFECORE BIOMEDICAL INC

6.17
-0.1700-2.68%
Post-market: 6.170.00000.00%16:05 EDT
Volume:79.55K
Turnover:495.25K
Market Cap:228.45M
PE:-4.14
High:6.40
Open:6.34
Low:6.15
Close:6.34
Loading ...
Apr 16, 2025

Major Issues Report

Form 8-K - Current report
Apr 10, 2025

Major Issues Report

Form 8-K - Current report
Apr 03, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 18, 2024

Correspondence

Form CORRESP - Correspondence
Oct 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 10, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities